Tous Actualités
Suivre
Abonner november Aktiengesellschaft

november Aktiengesellschaft

EANS-News: november Aktiengesellschaft
New Tests for Diagnosis of Borreliosis approved for use as CE IVD Products

Köln, Heidelber, Regensburg, Germany (euro adhoc) -

Additional CE certified tests from PROGEN / Multimetrix for a 
two-step diagnostic of Lyme Borreliosis are approved for laboratory 
diagnosis
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
New Products
Subtitle: Additional CE certified tests from PROGEN / Multimetrix for
a two-step diagnostic of Lyme Borreliosis are approved for laboratory
diagnosis
PROGEN Biotechnik
/ Multimetrix, a 100% subsidiary of november AG, are supplementing 
their multiplex product line and offer now new additional CE marked 
tests for the laboratory diagnosis of Lyme borreliosis. The 
requirements for the diagnosis of Lyme borreliosis established by the
National Reference Centre for Lyme borreliosis stipulate a two-step 
diagnostic procedure. Now the PROGEN/Multimetrix Luminex-based tests 
can implement these requirements. In addition to our confirmation 
assays (Borrelia IgM and IgG) new Borrelia Screening IgG and IgM 
Tests are now available for the first step of the diagnostic 
procedure. These tests allow for an automated, quantitative and 
sensitive detection of specific IgM and IgG antibodies in human 
samples. Also, in cases of suspected Lyme neuroborreliosis the 
Borrelia IgG and IgM Test as well as the Screening IgG Test are 
applicable for the detection of specific antibodies in cerebrospinal 
fluid. The PROGEN / Multimetrix multiplex tests for the laboratory 
diagnosis of Lyme borreliosis are a cost-effective alternative to 
conventional tests and offer an improved diagnostic reliability for 
both levels of the diagnostic procedure.
Borreliosis: Lyme borreliosis is the most common tick-borne 
infectious disease in the Northern hemisphere. In most European 
endemic regions, 20-40% of the tick vector Ixodes ricinus carry at 
least one of the three known pathogenic bacteria species Borrelia 
afzelii, Borrelia garinii, and the most common pathogen, Borrelia 
burgdorferi sensu stricto. Clinical symptoms and diagnosis of Lyme 
borreliosis is a multi-systemic disease with initial manifestations 
limited to characteristic ring-shaped skin lesions (erythema 
migrans), which can progress to systemic infection. The course of 
disease is divided into 3 stages (I-III). The clinical symptoms of 
Lyme disease are heterogeneous and depend on the tropism of the 
infectious agent. Preferential targets of the pathogen are connective
tissue of skin and joints, and the nervous system. A correlation 
between individual Borrelia species and defined clinical symptoms has
been observed. In serum IgM antibodies are usually not detectable 
until week 3 after infection.
Companies: november AG (www.november.eu) is an investment and holding
company, listed in the prime standard of the regulated market of the 
German stock exchange (Deutsche Börse), with special focus on medical
technology, biotechnology and environmental technologies and a 100% 
shareholder of the PROGEN Biotechnik GmbH. PROGEN Biotechnik GmbH, 
located in Heidelberg, Germany, (www.progen.de) is EN ISO 13485:2007 
certified and a manufacturer of in vitro diagnostics (Borreliosis, 
Hanta-Virus, FSME) and research products (antibodies, polypeptides, 
AAV, hyperphage) as well as specialist for the manufacturing of 
multiplex assays in bead-technology used for the Luminex® platform. 
The company is main shareholder of Multimetrix GmbH based in 
Regensburg, Germany (www.multimetrix.com). PROGEN is a member of the 
VDGH, a German association of diagnostic manufacturers.
end of announcement                               euro adhoc

Further inquiry note:

Dr. Dirk Zurek
CEO
Tel.: +49 (0) 221 82200 520 10
E-Mail: ir@november.de

Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Plus de actualités: november Aktiengesellschaft
Plus de actualités: november Aktiengesellschaft
  • 09.08.2010 – 10:39

    EANS-News: november Aktiengesellschaft

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Köln (euro adhoc) - Half-Year Results 2010 Confirm: november AG On Target Publication of consolidated operating results as of June 30, 2010 • PROGEN Biotechnik GmbH achieves positive operating results • Stable revenues of TEUR 1.806 • Consulting ...